Employees: 1,370
Size PCC Rokita Spolka Akcyjna (PCR.WA) is a Poland Materials company (Chemicals: Specialty) with a market value of $314M, the 78th largest of 82 Poland companies the cockpit tracks. Shares closed at PLN 62.30 on 18 Nov 2026.
Performance Over six months the shares fell 10.6%, against -30.4% for the median peer and +14.0% for the Poland market (cap-weighted) — 6th highest of 21 in its peer set.
Growth Revenue fell 0.9% over the last twelve months (peer median +12.5%); the operating margin is 5.0% (peer median 7.5%).
Valuation It trades at 10.0× forward earnings against a peer median of 9.8× (4th most expensive of 9).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 5.7 points below its cost of capital (9.9% WACC).
Next results Next results expected around 25 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | PLN 1.84B | PLN 1.80B | PLN 1.95B | PLN 2.39B | PLN 3.14B |
| Revenue growth | — | -8% | -18% | -24% | — |
| Gross profit | PLN 353M | PLN 326M | PLN 391M | PLN 583M | PLN 1.15B |
| EBITDA | PLN 243M | PLN 188M | PLN 278M | PLN 459M | PLN 993M |
| Net income | PLN 113M | PLN 61.5M | PLN 143M | PLN 268M | PLN 675M |
| Free cash flow | PLN 177M | PLN 119M | PLN 145M | PLN 265M | PLN 535M |
| Capital expenditure | PLN 96.8M | PLN 152M | PLN 129M | PLN 216M | PLN 229M |
| Total debt | PLN 499M | PLN 545M | PLN 640M | PLN 599M | PLN 643M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PCR.WA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.4% | -13.0% | 4th highest of 21 |
| 6-month return | -10.6% | -30.4% | 6th highest of 21 |
| Distance from 52-week high | -16.3% | -46.5% | 2nd highest of 21 |
| Revenue growth (TTM) | -0.9% | +12.5% | 7th lowest of 21 |
| Operating margin | 5.0% | 7.5% | 8th lowest of 21 |
| Forward P/E | 10.0× | 9.8× | 4th most expensive of 9 |
| Growth the price implies (Req g, 7 yrs) | 8.4% | 7.5% | 4th most demanding of 9 |
| Growth delivered (Del g) | +4.1% | +5.4% | 5th highest of 9 |
| Hurdle (Req g minus delivered) | +4.4 pp | +0.0 pp | 4th most demanding of 9 |
| ROIC minus cost of capital | -5.7 pp | -2.2 pp | 7th lowest of 21 |
| EV / EBITDA | 6.6× | 6.3× | 6th most expensive of 13 |
| Net debt / EBITDA | 1.4× | 0.1× | 4th most indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| PCC Rokita Spolka Akcyjna PCR.WA | Poland | $314M | -11% | -1% | 5% | 10.0× | 8.4% | +4.1% |
| Rasa Industries,Ltd 4022.T | Japan | $315M | -38% | +16% | 12% | 9.6× | 7.7% | +10.5% |
| Aekyung Chemical 161000.KS | South Korea | $313M | -40% | +16% | 3% | n/a | n/a | n/a |
| Weifang Yaxing Chemical 600319.SS | China | $311M | -32% | -1% | -9% | n/a | n/a | n/a |
| Zhejiang Wanfeng Chemical 603172.SS | China | $317M | -30% | +17% | 11% | n/a | n/a | n/a |
| WONIK Materials 104830.KS | South Korea | $317M | -31% | +17% | 18% | 7.2× | -8.3% | +3.1% |
| Premier Explosives PREMEXPLN.NS | India | $311M | +3% | -9% | 5% | n/a | n/a | n/a |
| Tayca 4027.T | Japan | $311M | +20% | +17% | 6% | n/a | n/a | n/a |
| Trualt Bioenergy TRUALT.NS | India | $309M | -27% | -5% | 14% | 9.9× | n/a | n/a |
| Longxing Technology 002442.SZ | China | $319M | -29% | +7% | 1% | n/a | n/a | n/a |
| PI Advanced Materials 178920.KS | South Korea | $307M | -54% | -2% | 22% | 9.0× | -10.8% | +0.1% |
| Anhui Annada Titanium Industry 002136.SZ | China | $306M | -35% | +12% | 2% | n/a | n/a | n/a |
| Shenzhen Tongyi Industry 300538.SZ | China | $305M | -34% | -31% | -3% | n/a | n/a | n/a |
| Wuxi Acryl Technology 603722.SS | China | $327M | -43% | +34% | -15% | n/a | n/a | n/a |
| Henan Qingshuiyuan Technology 300437.SZ | China | $327M | -40% | +13% | -1% | n/a | 26.9% | -6.8% |
| Shandong Keyuan Pharmaceutical 301281.SZ | China | $298M | -18% | +33% | 15% | n/a | n/a | n/a |
| T&L 340570.KS | South Korea | $331M | -1% | -5% | 34% | 8.7× | -15.9% | +32.2% |
| Polyplex POLYPLEX.NS | India | $332M | +11% | +16% | 6% | n/a | 17.3% | +7.6% |
| Tomoe Engineering 6309.T | Japan | $333M | +3% | +2% | 9% | 12.5× | n/a | n/a |
| Stella Chemifa 4109.T | Japan | $333M | -28% | +9% | 11% | 14.9× | 7.2% | +2.3% |
| Toyo Gosei 4970.T | Japan | $335M | -58% | +21% | 14% | 11.9× | 11.9% | +9.1% |